Dr. Veronica A. Kon Graversen, MD

Dr. Kon Graversen practices at Retina Health Center Pl in Fort Myers, Florida.

Dr. Kon Graversen's NPI, 1467773838, was assigned on June 18, 2010. Dr. Kon Graversen graduated from Universidad Catolica de Santiago de Guayaquil in 2002. Dr. Kon Graversen holds Florida license ME139314.

Dr. Kon Graversen's primary practice is Retina Health Center Pl, at 1567 Hayley Ln Suite 101 Suite 101, Fort Myers, FL 33907-2109. The practice phone is (239) 337-3337.

Dr. Kon Graversen's primary practice is Retina Health Center Pl in Fort Myers, Florida. Dmand AI also links Dr. Kon Graversen to 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kon Graversen practices, 2 sites in all. Vendor and product names are available with a free account.

Retina specialist is Dr. Kon Graversen's primary specialty in the NPI Registry, under taxonomy code 207WX0107X. Dr. Kon Graversen is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Kon Graversen's licenses on file in 4 states: Florida, Ohio, North Carolina and Pennsylvania.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eyelid inflammation and glaucoma among the conditions Dr. Kon Graversen treats.

CMS data shows 72,722 Medicare services from Dr. Kon Graversen across 29 procedure codes in 2024, for 2,225 Medicare patients. Medicare paid $4,984,135 for them.

CMS counts 2,225 Medicare patients who saw Dr. Kon Graversen in 2024. The largest group is 75 to 84, with 930 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 2% are also on Medicaid. Their average risk score is 1.43, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kon Graversen's median patient age at 78, with 55% women.

In 2024, Dr. Kon Graversen wrote 1,650 Medicare Part D claims for 569 patients. 69% of them were for generic drugs. CMS names the drug for 1,517 of them, across 20 drugs with 11 or more claims each, at $50,837 in total drug cost. In 2023, CMS named 1,337 claims across 19 drugs.

Dr. Kon Graversen accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 7 papers to Dr. Kon Graversen, published from 2019 to 2020. 2020 was the busiest year, with 3. The most frequent topics are Intravitreal Injections. Dr. Kon Graversen's most frequent co-authors are Timothy G. Murray, MBA, MD, Alexander J. Brucker, MD and Seema Garg, MD.

CMS Open Payments shows 18 general payments to Dr. Kon Graversen from 9 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 99% of the total. Apellis Pharmaceuticals, Inc. paid the most, $427.

Dr. Kon Graversen graduated from Universidad Catolica de Santiago de Guayaquil in 2002.

Dr. Kon Graversen is in network with 17 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.